(Reuters) - U.S. health regulators have approved a new breast cancer drug from Roche Holding AG that the company hopes will become the standard treatment for women with an aggressive, incurable form of cancer.

Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/faEmyOoQqkg/us-roche-fda-idUSBRE85801L20120609
phlebotomy certification courses pharmacy technician courses phlebotomy course toronto
No comments:
Post a Comment